首页> 美国卫生研究院文献>Hepatitis Monthly >Cost-Effectiveness Analysis of Adding Low Dose Ribavirin to Peginterferon Alfa-2a for Treatment of Chronic Hepatitis C Infected Thalassemia Major Patients in Iran

【2h】

Cost-Effectiveness Analysis of Adding Low Dose Ribavirin to Peginterferon Alfa-2a for Treatment of Chronic Hepatitis C Infected Thalassemia Major Patients in Iran

机译：在Peginterferon Alfa-2a中添加小剂量利巴韦林治疗慢性丙型肝炎感染地中海贫血重症患者的成本-效果分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe prevalence of hepatitis C in Iran is 1% and 18% in general population and thalassemia patients respectively. The cost effectiveness analysis of adding Ribavirin to Peginterferon alfa-2a (PEG IFN alfa-2a) as a combination treatment strategy of chronic hepatitis C in thalassemia patients in comparison with monotherapy could help clinicians and policy makers to provide the best treatment for the patients.

机译：背景伊朗丙型肝炎的患病率是普通人群和地中海贫血患者的1％和18％。与单一疗法相比，在地中海贫血患者中将利巴韦林加到Peginterferon alfa-2a（PEG IFN alfa-2a）中作为慢性丙型肝炎的联合治疗策略，其成本效益分析可帮助临床医生和决策者为患者提供最佳治疗。

著录项

期刊名称 Hepatitis Monthly
作者
Alireza Mehrazmay; Seyed Moayed Alavian; Maziar Moradi-Lakeh; Mahdi Mokhtari Payam; Amir Hashemi-Meshkini; Bita Behnava; Seyyed Mohammad Miri; Pegah Karimi Elizee; Seyed Vahid Tabatabaee; Maryam Keshvari; Kamran Bagheri Lankarani;
展开▼
作者单位

展开▼
年(卷),期 2013(13),9
年度 2013
页码 e10236
总页数 8
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
Hepatitis C PEG-Interferon Alfa-2a Ribavirin Cost-Benefit Analysis Decision Support Techniques Iran;

机译：丙型肝炎;PEG-干扰素Alfa-2a;利巴韦林;成本效益分析;决策支持技术;伊朗;

相似文献

外文文献
中文文献
专利

1. Cost-Effectiveness Analysis of Adding Low Dose Ribavirin to Peginterferon Alfa-2a for Treatment of Chronic Hepatitis C Infected Thalassemia Major Patients in Iran [J] . Alireza Mehrazmay, Seyed Moayed Alavian, Maziar Moradi-Lakeh, Hepatitis Monthly . 2013,第9期

机译：在Peginterferon Alfa-2a中添加小剂量利巴韦林治疗慢性丙型肝炎感染地中海贫血重症患者的成本-效果分析
2. COST-EFFECTIVENESS ANALYSIS OF ADDING LOW DOSE RIBAVIRIN TO PEGINTERFERON ALFA-2A FOR TREATMENT OF CHRONIC HEPATITIS C INFECTED THALASSEMIA MAJOR PATIENTS IN IRAN [J] . MEHRAZMAY ALIREZA, ALAVIAN SEYED MOAYED, MORADI LAKEH MAZIAR, Hepatitis Monthly . 2013,第9期

机译：低剂量利巴韦林与聚乙二醇干扰素ALFA-2A联合治疗慢性丙型肝炎并发地中海贫血患者的成本效益分析
3. Full-dose peginterferon Alfa-2a and low-dose ribavirin treatment of genotypes 1 and 4 chronic hepatitis C patients with end-stage renal disease. [J] . Abdulhadi Ali MM, Alsaudi D, Agha A, Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2011,第11期

机译：全剂量聚乙二醇干扰素Alfa-2a和低剂量利巴韦林治疗基因型1和4的慢性丙型肝炎并伴有终末期肾脏疾病的患者。
4. Patients with HCV/HIV Co-infection Achieving a Sustained Virological Response Following HCV Treatment with Peginterferon alfa-2a (PEGASYS) plus Ribavirin (COPEGUS) have Improved Health Related Quality of Life [C] . D.T. Dieterich, M. Rodriguez Torres, J.K. Rockstroh International AIDS Conference . 2004

机译：HCV / HIV的患者在用Peginterferon Alfa-2a（Pegasys）加上利巴韦林（Copegegs）后HCV治疗后实现持续的病毒学反应，具有改善的健康相关的生活质量
5. Population pharmacokinetics and efficacy of ribavirin in patients with chronic hepatitis C genotype 1 infection. [D] . Jin, Runyan. 2010

机译：利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
6. Low Dose Ribavirin for Treatment of Hepatitis C Virus Infected Thalassemia Major Patients; New Indications for Combination Therapy [O] . Seyed Vahid Tabatabaei, Seyed Moayed Alavian, Maryam Keshvari, 2012

机译：低剂量利巴韦林治疗丙型肝炎病毒感染的地中海贫血重症患者；联合疗法的新适应症
7. Cost-Effectiveness Analysis of Adding Low Dose Ribavirin to Peginterferon Alfa-2a for Treatment of Chronic Hepatitis C Infected Thalassemia Major Patients in Iran [O] . Alireza Mehrazmay, Seyed-Moayed Alavian, Maziar Moradi-Lakeh, 2013

机译：将低剂量利纳韦林与Peginterferon Alfa-2A添加到治疗慢性丙型肝炎的成本效果分析

Cost-Effectiveness Analysis of Adding Low Dose Ribavirin to Peginterferon Alfa-2a for Treatment of Chronic Hepatitis C Infected Thalassemia Major Patients in Iran

摘要

著录项

相似文献

相关主题

期刊订阅